What to know about acupuncture, hydrotherapy and cognitive behavioral therapy for chronic low back pain.

The FDA approved a new table that combines Tylenol with naproxen, an anti-inflammatory medication.

July 24 (Reuters) - The U.S. Food and Drug Administration on Friday approved a nonprescription, fixed-dose pill that combines Kenvue's Tylenol with the nonsteroidal anti-inflammatory drug naproxen for ...

Back pain treatment drug research cleared a major hurdle: University of Edinburgh scientists mapped the molecular chain ...

If you're suffering from chronic back pain, chances are you're familiar with this common medication. But using it may put your future brain health at risk.

The new pills can lower cholesterol levels far below what can be achieved with statins, clinical trials have shown. By Gina Kolata The Food and Drug Administration approved a daily pill on Thursday ...

Detailed phase 3 results suggest the two-drug combination of Gilead Sciences’ lenacapavir and Merck & Co.’s islatravir has what it takes to become the first complete weekly pill for the treatment of ...

The Food and Drug Administration on Thursday approved a new cholesterol pill from Merck that works in a different way from statins. The daily pill, called Lipfendra, is known as a PCSK9 inhibitor — a ...

The U.S. Food and Drug Administration has approved a new cholesterol-busting drug that appears to reduce harmful cholesterol far below levels than can be achieved using statins. Statins have long been ...